RA Capital Management, L.P. 13D and 13G filings for Aerpio Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-11-15 4:33 pm Sale |
2021-11-15 | 13G | Aerpio Pharmaceuticals, Inc. ARPO |
RA Capital Management, L.P. | 0 0.000% |
-165,749 (Position Closed) |
Filing |
| 2021-08-23 4:30 pm Purchase |
2021-08-11 | 13G | Aerpio Pharmaceuticals, Inc. ARPO |
RA Capital Management, L.P. | 165,749 5.220% |
60,762 (+57.88%) |
Filing |
| 2021-07-12 4:30 pm Purchase |
2021-06-30 | 13G | Aerpio Pharmaceuticals, Inc. ARPO |
RA Capital Management, L.P. | 104,987 3.300% |
104,987 (New Position) |
Filing |